The FDA has declined to approve glatiramer acetate (GA) depot in the treatment of relapsing types of multiple sclerosis (MS), issuing a complete response letter (CRL) for the long-acting ...
Results: Scoring 777 and 756 out of a possible 800 points, iFacts and Lexi-Interact, respectively, provided the most competent, complete, use-friendly compendia for assessment of drug interactions.